TradingView
AlenCiken
13 июля 2018 г., 21:17
CLBS granted regenerative medicine advanced therapy by FDA
Длинная
NASDAQ:CLBS
240
Описание
⋅
13 июля 2018 г., 21:17
Caladrius Receives FDA Regenerative Medicine Advanced Therapy Designation for CD34+ Cell Therapy for Treating Refractory Angina
caladrius.com/press-release/caladrius-receives-fda-regenerative-medicine-advanced-therapy-designation-for-cd34-cell-therapy-for-treating-refractory-angina/
Trend Analysis
Chart Patterns
Technical Indicators
Ещё